8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Appl Biochem Biotechnol

Bioeffects Seen

Authors not listed · 2013

Share:

This biotechnology study on enzyme modification has no relevance to EMF exposure or electromagnetic health effects.

Plain English Summary

Summary written for general audiences

Researchers modified HIV reverse transcriptase enzymes through genetic mutations to make them more heat-stable for laboratory use. The modified enzymes could function at temperatures up to 68°C compared to 62-66°C for unmodified versions. This biotechnology research aimed to improve tools for DNA synthesis in laboratory applications.

Why This Matters

This study appears to be purely biotechnological research focused on improving laboratory enzymes, with no direct connection to electromagnetic field exposure or EMF health effects. The research involves genetic modification of viral enzymes to enhance their thermal stability for potential use in molecular biology applications. While the study demonstrates interesting advances in enzyme engineering, it doesn't provide insights into EMF exposure risks or biological responses to electromagnetic radiation. The research belongs in the broader category of biotechnology and molecular biology rather than EMF health research.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2013). Appl Biochem Biotechnol.
Show BibTeX
@article{appl_biochem_biotechnol_ce2587,
  author = {Unknown},
  title = {Appl Biochem Biotechnol},
  year = {2013},
  doi = {10.1007/s10529-013-1321-4},
  
}

Quick Questions About This Study

No, this research focused entirely on genetic modification of viral enzymes to improve their heat stability. There was no electromagnetic field exposure or radiation testing involved in this biotechnology study.
It isn't relevant to EMF research. This appears to be a database categorization error. The study deals with laboratory enzyme engineering for molecular biology applications, not electromagnetic field health effects.
The genetically modified HIV-1 enzymes could function at temperatures up to 68°C, compared to 62-66°C for the original unmodified enzymes, representing a 2-6 degree improvement in heat tolerance.
No direct relationship exists between this enzyme engineering research and EMF exposure effects. The study examined genetic mutations affecting protein structure, not electromagnetic radiation responses or cellular EMF sensitivity.
The D443A mutation eliminated RNase H activity while improving thermal stability. This genetic change allowed the modified enzymes to maintain DNA synthesis activity at higher temperatures than wild-type versions.